|
Real-time Estimate
Cboe BZX
16:23:10 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.700 USD | -0.10% |
|
+2.60% | -7.95% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.10% | +2.60% | +4.71% | -10.43% | -7.95% | +58.44% | -20.49% | -19.46% | - | 1.33B | |
| +2.07% | +10.05% | +31.65% | +47.13% | +79.09% | +77.41% | +106.53% | +16.62% | - | 70.1B | |
| -0.60% | +0.34% | -0.42% | +10.07% | +5.52% | +37.33% | +65.48% | +183.72% | +5,393.10% | 54.93B | |
| -3.51% | -3.36% | +17.37% | +8.56% | -26.40% | +4.25% | +474.42% | +443.70% | +921.49% | 28.89B | |
| +0.04% | +12.56% | +20.44% | +35.67% | +45.42% | +54.67% | +5.47% | -61.93% | - | 23.9B | |
| +0.09% | +1.85% | +3.12% | +0.70% | -2.44% | -17.64% | -13.55% | -75.38% | - | 23.3B | |
| +0.35% | +8.24% | +12.45% | +125.44% | +241.04% | +252.94% | +466.50% | +1,800.42% | +864.12% | 18.41B | |
| -0.59% | +7.88% | +6.38% | +20.25% | -0.10% | +40.87% | -20.12% | -31.36% | +78.73% | 18.77B | |
| -0.57% | +6.85% | +1.74% | +14.04% | +33.99% | +30.20% | +580.70% | - | - | 16.1B | |
| +0.47% | -3.05% | -9.69% | -1.33% | +15.47% | +31.49% | +135.29% | +176.86% | +370.35% | 12.48B | |
| +0.06% | +2.21% | +18.38% | +12.65% | +32.14% | +338.87% | +198.50% | +44.96% | +1,333.50% | 12.32B | |
| -1.64% | +3.71% | -0.32% | +2.01% | -9.11% | +41.73% | +205.18% | +523.73% | +6,406.45% | 12.39B | |
| -1.66% | +9.97% | -2.68% | -20.76% | -14.87% | -44.59% | +652.02% | +88.01% | +120.59% | 12.05B | |
| +1.47% | +8.48% | +6.53% | -20.31% | -8.32% | -33.80% | +208.79% | +135.99% | - | 11.98B | |
| -0.52% | -6.96% | -7.94% | -1.96% | +19.15% | +105.29% | +135.86% | +135.49% | +523.13% | 10.52B | |
| +0.24% | -0.06% | -1.90% | -13.07% | +14.58% | +25.19% | +119.41% | -26.34% | - | 8.99B | |
| -1.80% | -0.73% | +9.54% | +34.54% | +213.40% | +490.06% | +771.93% | -31.89% | -12.43% | 9.18B | |
| -0.02% | +0.68% | +0.98% | +125.43% | +81.50% | +180.79% | +401.72% | +279.56% | - | 8.96B | |
| +0.60% | +2.37% | +5.71% | +11.12% | +30.66% | +91.08% | +31.05% | +131.60% | - | 8.88B | |
| -0.84% | +4.58% | -1.73% | -6.07% | +286.62% | +171.45% | +313.78% | -31.96% | - | 8.2B | |
| Average | -0.31% | +5.28% | +5.72% | +18.69% | +51.47% | +96.80% | +240.92% | +193.81% | +1,599.90% | 18.58B | |
| Weighted average by Cap. | -0.10% | +6.71% | +10.28% | +23.94% | +45.55% | +76.12% | +202.29% | +195.77% | +2,356.15% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
